You just read:

OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2™ Trial in Metastatic Bladder Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

Oct 25, 2016, 17:00 ET